Oncolytics Biotech (ONCY) Tops Q3 EPS by 3c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• KB Home (KBH) Tops Q3 EPS by 16c
• Goldman: 'Our key conclusion is that AI is likely to be credit-positive for banks', 'Rearming Our Overweight Stance on Banks'
• AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue